CME/CE

Use the tool below to view all available Medtelligence Series

NEW EPISODE
Beyond the IV Pole: Introducing SC Furosemide
Beyond the IV Pole: Introducing SC Furosemide
MinuteCE®
Beyond the IV Pole: Introducing SC Furosemide
Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
1.00 program credit
- Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
1.00 program credit
NEW EPISODE
Closing the Loop: Coordinated Remote Management
Closing the Loop: Coordinated Remote Management
MinuteCE®
Closing the Loop: Coordinated Remote Management
Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP; Stephanie Barnes DNP, AGPNP-C, CHFN
1.00 program credit
- Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
- Stephanie Barnes DNP, AGPNP-C, CHFN
1.00 program credit
NEW EPISODE
Measuring the Shift: From Admission to Prevention
Measuring the Shift: From Admission to Prevention
MinuteCE®
Measuring the Shift: From Admission to Prevention
Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP; Stephanie Barnes DNP, AGPNP-C, CHFN
1.00 program credit
- Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
- Stephanie Barnes DNP, AGPNP-C, CHFN
1.00 program credit
Non-Obstructive HCM in Focus: Symptoms, Quality of Life, and Unmet Therapeutic Need
Non-Obstructive HCM in Focus: Symptoms, Quality of Life, and Unmet Therapeutic Need
CME/CE
Non-Obstructive HCM in Focus: Symptoms, Quality of Life, and Unmet Therapeutic Need
Ahmad Masri, MD, MS; Michelle Michels, MD, PhD
0.50 credits
- Ahmad Masri, MD, MS
- Michelle Michels, MD, PhD
0.50 credits
Obicetrapib: Mechanism Meets Clinical Impact
Obicetrapib: Mechanism Meets Clinical Impact
MinuteCE®
Obicetrapib: Mechanism Meets Clinical Impact
Christie Ballantyne, MD
1.00 program credit
- Christie Ballantyne, MD
1.00 program credit
CETP Inhibition: A Class Reborn
CETP Inhibition: A Class Reborn
MinuteCE®
CETP Inhibition: A Class Reborn
Christie Ballantyne, MD; Erin Michos
1.00 program credit
- Christie Ballantyne, MD
- Erin Michos
1.00 program credit
What Comes Next: Building the Future Lipid Toolbox
What Comes Next: Building the Future Lipid Toolbox
MinuteCE®
What Comes Next: Building the Future Lipid Toolbox
Christie Ballantyne, MD; Erin Michos
1.00 program credit
- Christie Ballantyne, MD
- Erin Michos
1.00 program credit
Beyond Lipids: Metabolic and Renal Implications of CETP Inhibition
Beyond Lipids: Metabolic and Renal Implications of CETP Inhibition
MinuteCE®
Beyond Lipids: Metabolic and Renal Implications of CETP Inhibition
Erin Michos
1.00 program credit
- Erin Michos
1.00 program credit
Lipids and the Brain: Extending Cardiovascular Risk Reduction to Neurodegenerative Disease
Lipids and the Brain: Extending Cardiovascular Risk Reduction to Neurodegenerative Disease
MinuteCE®
Lipids and the Brain: Extending Cardiovascular Risk Reduction to Neurodegenerative Disease
Christie Ballantyne, MD; Philip Scheltens, MD, PhD
1.00 program credit
- Christie Ballantyne, MD
- Philip Scheltens, MD, PhD
1.00 program credit
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
MinuteCE®
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
James Burton, DM, FRCP; Pauline A. Swift, PhD
1.00 program credit
- James Burton, DM, FRCP
- Pauline A. Swift, PhD
1.00 program credit
MinuteCE®
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
James Burton, DM, FRCP; Nihar R. Desai, MD, MPH
1.00 credit 8 episodes
- James Burton, DM, FRCP
- Nihar R. Desai, MD, MPH
- Ellie Kelepouris, MD, FACP, FAHA
- Pauline A. Swift, PhD
1.00 credit 8 episodes
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
MinuteCE®
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
Ellie Kelepouris, MD, FACP, FAHA; Pauline A. Swift, PhD
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Pauline A. Swift, PhD
1.00 program credit
Individualizing Management Strategies for PSVT: Incorporating Patient Preference
Individualizing Management Strategies for PSVT: Incorporating Patient Preference
MinuteCE®
Individualizing Management Strategies for PSVT: Incorporating Patient Preference
Jennifer Carlquist, PA-C; Sean Pokorney, MD, MBA
1.00 program credit
- Jennifer Carlquist, PA-C
- Sean Pokorney, MD, MBA
- Brian P. Rose, PA-C, MPH
1.00 program credit
Choosing the Right Therapy for Patients With PSVT
Choosing the Right Therapy for Patients With PSVT
MinuteCE®
Choosing the Right Therapy for Patients With PSVT
Jennifer Carlquist, PA-C; Brian P. Rose, PA-C, MPH
1.00 program credit
- Jennifer Carlquist, PA-C
- Brian P. Rose, PA-C, MPH
1.00 program credit
Ambulatory Monitoring Approaches for PSVT: Which One and When?
Ambulatory Monitoring Approaches for PSVT: Which One and When?
MinuteCE®
Ambulatory Monitoring Approaches for PSVT: Which One and When?
Jennifer Carlquist, PA-C; Brian P. Rose, PA-C, MPH
1.00 program credit
- Jennifer Carlquist, PA-C
- Brian P. Rose, PA-C, MPH
1.00 program credit
MinuteCE®
Improving Outcomes in PSVT: Best Practices for Choosing Optimal Management Strategies
Jennifer Carlquist, PA-C; Sean Pokorney, MD, MBA
1.00 credit 8 episodes
- Jennifer Carlquist, PA-C
- Sean Pokorney, MD, MBA
- Brian P. Rose, PA-C, MPH
1.00 credit 8 episodes

CME/CE

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

CME/CE

Popular

Title

NEED HELP?

Contact us